Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients
出版年份 2014 全文链接
标题
Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients
作者
关键词
-
出版物
HEPATOLOGY
Volume 61, Issue 1, Pages 46-55
出版商
Wiley
发表日期
2014-08-15
DOI
10.1002/hep.27369
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Hepatic Decompensation in Antiretroviral-Treated Patients Co-Infected With HIV and Hepatitis C Virus Compared With Hepatitis C Virus–Monoinfected Patients
- (2014) Vincent Lo Re et al. ANNALS OF INTERNAL MEDICINE
- HIV-1 Infected Peripheral Blood Mononuclear Cells Modulate the Fibrogenic Activity of Hepatic Stellate Cells through Secreted TGF-β and JNK Signaling
- (2014) Deepti Gupta et al. PLoS One
- Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection
- (2014) P. Gupta et al. VIROLOGY
- Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver
- (2013) Hiroya Yamada et al. CLINICA CHIMICA ACTA
- Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B
- (2013) Keiko Arataki et al. JOURNAL OF MEDICAL VIROLOGY
- Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: Multi-site study
- (2013) Andrea D. Branch et al. LIVER TRANSPLANTATION
- Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damage
- (2013) Takashi Nagano et al. NANOTECHNOLOGY
- MicroRNAs in liver disease
- (2013) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- Treatment of HCV Infection by Targeting MicroRNA
- (2013) Harry L.A. Janssen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinetics of miR-122 Expression in the Liver during Acute HCV Infection
- (2013) Youkyung Choi et al. PLoS One
- The role of microRNAs in HIV-1 pathogenesis and therapy
- (2012) Sanjay Swaminathan et al. AIDS
- Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients
- (2012) Mattias Mandorfer et al. AIDS
- Epigenetic Regulation of miR-34a Expression in Alcoholic Liver Injury
- (2012) Fanyin Meng et al. AMERICAN JOURNAL OF PATHOLOGY
- Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers
- (2012) Johannes Vermehren et al. BMC GASTROENTEROLOGY
- Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis
- (2012) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122
- (2012) A. J. van der Meer et al. JOURNAL OF VIRAL HEPATITIS
- Hepatitis B Virus-Specific miRNAs and Argonaute2 Play a Role in the Viral Life Cycle
- (2012) C. Nelson Hayes et al. PLoS One
- Liver-specific microRNA-122: Biogenesis and function
- (2012) Catherine Jopling RNA Biology
- Hepatic MicroRNA Profiles Offer Predictive and Mechanistic Insights After Exposure to Genotoxic and Epigenetic Hepatocarcinogens
- (2012) Costas Koufaris et al. TOXICOLOGICAL SCIENCES
- MicroRNAs, Hepatitis C Virus, and HCV/HIV-1 Co-Infection: New Insights in Pathogenesis and Therapy
- (2012) Archana Gupta et al. Viruses-Basel
- Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis
- (2012) Natalia Elfimova et al. Frontiers in Physiology
- microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis
- (2012) Andrea Noetel et al. Frontiers in Physiology
- Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection
- (2011) Verena Bihrer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Establishment of a Novel Permissive Cell Line for the Propagation of Hepatitis C Virus by Expression of MicroRNA miR122
- (2011) H. Kambara et al. JOURNAL OF VIROLOGY
- Increasing burden of liver disease in patients with HIV infection
- (2011) Deepak Joshi et al. LANCET
- Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver
- (2011) Kirandeep Kaur et al. Molecular BioSystems
- Mir-34a Is Upregulated during Liver Regeneration in Rats and Is Associated with the Suppression of Hepatocyte Proliferation
- (2011) Huan Chen et al. PLoS One
- Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
- (2011) Silvia Cermelli et al. PLoS One
- Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine
- (2010) Nicolás Merchante et al. ANTIVIRAL THERAPY
- Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
- (2010) Michelle DallaPiazza et al. BMC INFECTIOUS DISEASES
- Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus
- (2009) Juan Macías et al. HEPATOLOGY
- HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension
- (2009) T. Reiberger et al. JOURNAL OF VIRAL HEPATITIS
- Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
- (2009) R. E. Lanford et al. SCIENCE
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
- (2008) Witold Filipowicz et al. NATURE REVIEWS GENETICS
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More